Moderna Claims Its Vaccine 100% Potent Against COVID; Pushes For US, EU Nod

Claiming 100% success rate against the severe cases, US-based Moderna Inc has planned to secure US and EU emergency authorization for its COVID-19 vaccine. While the late stage trials of the vaccine showed 94.1% efficacy, it reported no serious health concerns. Probably Moderna may become the second vaccine-maker to get the US emergency nod after Pfizer with 95% efficacy. Moderna claimed its vaccine has consistent potency across all age, race and gender.